BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11204961)

  • 1. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
    Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
    Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
    Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
    Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
    Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
    Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
    Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of life expectancy in medullary thyroid cancer: age does not matter.
    de Groot JW; Plukker JT; Wolffenbuttel BH; Wiggers T; Sluiter WJ; Links TP
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):729-36. PubMed ID: 17121523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
    Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
    Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
    Torresan F; Cavedon E; Mian C; Iacobone M
    World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
    Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
    J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma.
    Hamy A; Pessaux P; Mirallié E; Mucci-Hennekinne S; Gibelin H; Mor-Martinez C; de Calan L; Ronceray J; Kraimps JL
    Eur J Surg Oncol; 2005 Sep; 31(7):774-7. PubMed ID: 15925476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of sporadic medullary thyroid cancer.
    Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
    J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.